Gilead Secures Approvals for Arcellx Acquisition Deal
FOSTER CITY, Calif., April 17, 2026 Gilead Sciences, Inc. has announced that it has obtained all required regulatory approvals...
CAR-T therapy
Advertisement
BioOra and Cincinnati Advance CAR-T Therapy in Leukemia
Wellington, New Zealand & Cincinnati, Ohio | April 13, 2026 BioOra Limited and Cincinnati Children’s Hospital Medical Center have...
Allogene to Reveal ALPHA3 CAR-T Trial Data Soon
South San Francisco, California | April 10, 2026 Allogene Therapeutics has announced that it will present the interim futility...
Oricell Therapeutics Secures $110M for CAR-T Expansion
SHANGHAI, China, April 10, 2026 Oricell Therapeutics Holdings Limited has successfully closed a $110 million pre-IPO financing round, marking...
BioOra and Octane Expand CAR-T Manufacturing Globally
WELLINGTON, New Zealand & KINGSTON, Canada, April 7, 2026 BioOra Limited and Octane Biotech Inc. announced a strategic Letter...
Advertisements
AvenCell Therapeutics Advances Next-Gen CAR-T Therapy
CAMBRIDGE, Mass., April 2, 2026 AvenCell Therapeutics, Inc. has achieved a major regulatory milestone with both the U.S. FDA...
FDA Clears NexSys PCS Plasma System With Persona PLUS
BOSTON, Feb. 23, 2026 — Haemonetics Corporation announced that the U.S. Food and Drug Administration granted 510(k) clearance for...
Anixa CAR-T Breakthrough Highlighted at SCTR 2026
SAN JOSE, Calif., Feb. 23, 2026 — Anixa Biosciences announced that immunology leader Jose Conejo-Garcia, M.D., Ph.D., will keynote...
AI Drug Discovery Pact Targets Next-Gen Therapies
SAN DIEGO, Calif. & CAMBRIDGE, Mass., Feb. 9, 2026 — Clinical-stage life science technology company Iambic Therapeutics has entered...
Anixa Advances CAR-T Dose Escalation in Ovarian Cancer
SAN JOSE, Calif., Feb. 9, 2026 — Anixa Biosciences reported encouraging survival observations from its ongoing Phase 1 ovarian...
Advertisement
